%0 Journal Article
%A Eichkorn, Tanja
%A Lischalk, Jonathan W
%A Hörner-Rieber, Juliane
%A Deng, Maximilian
%A Meixner, Eva
%A Krämer, Anna
%A Hoegen, Philipp
%A Sandrini, Elisabetta
%A Regnery, Sebastian
%A Held, Thomas
%A Harrabi, Semi
%A Jungk, Christine
%A Herfarth, Klaus
%A Debus, Jürgen
%A König, Laila
%T Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
%J Journal of neuro-oncology
%V 162
%N 3
%@ 0167-594x
%C Dordrecht [u.a.]
%I Springer Science + Business Media B.V
%M DKFZ-2023-00023
%P 489-501
%D 2023
%Z 2023 May;162(3):489-501
%X Proton beam radiotherapy (PRT) has been demonstrated to improve neurocognitive sequelae particularly. Nevertheless, following PRT, increased rates of radiation-induced contrast enhancements (RICE) are feared. How safe and effective is PRT for IDH-mutated glioma WHO grade 2 and 3?We analyzed 194 patients diagnosed with IDH-mutated WHO grade 2 (n = 128) and WHO grade 3 (n = 66) glioma who were treated with PRT from 2010 to 2020. Serial clinical and imaging follow-up was performed for a median of 5.1 years.For WHO grade 2, 61
%K Efficacy (Other)
%K IDH-mutation (Other)
%K Low and intermediate grade glioma (Other)
%K Proton radiotherapy (Other)
%K Radiation-induced contrast enhancement (RICE) (Other)
%K Safety (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:36598613
%R 10.1007/s11060-022-04217-y
%U https://inrepo02.dkfz.de/record/186587